CMMB
Chemomab Therapeutics
CMMB
CMMB
5 hedge funds and large institutions have $1.51M invested in Chemomab Therapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.
Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIC
1
AWM Investment Company
New York
|
$438K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $521K | 372,058 | -30,541 | -8% |
|
|
PCM
2
Palisade Capital Management
Fort Lee,
New Jersey
| $517K | 369,640 | – | – |
|
|
AIC
3
AWM Investment Company
New York
| $438K | 312,980 | +312,980 | New |
|
|
PF
4
Phoenix Financial
Givatayim,
Israel
| $36K | 26,087 | – | – |
|
|
KCM
5
Kennedy Capital Management
St Louis,
Missouri
| – | – | -128,387 | Closed |
|
6
Fidelity Investments
Boston,
Massachusetts
| – | – | -21,700 | Closed |
|
|
VF
7
Virtu Financial
New York
| – | – | -13,086 | Closed |
|
8
Morgan Stanley
New York
| – | – | -10,870 | Closed |
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -319 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $0 | 100 | -296 | -75% |
|
|
CFGS
11
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|